Multiple Sclerosis Market Set to Reach USD 33.57 Billion by 2032, Growing at a CAGR of 5.4% | Polaris Market Research (PMR) New York, USA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview: The multiple sclerosis market was estimated at USD 21.04 billion in 2023. The market valuation is expected to be USD 33.57 billion...

Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...

Multiple Sclerosis Drugs Market Worth $40.66 Bn at 7.1% CAGR; Industry Bigwigs Such as Novartis and Biogen to Focus on Introducing Cost-Effective MS Treatments: Fortune Business Insights™ Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. ...

Multiple Sclerosis Drugs Market to Hit USD 40.66 Bn by 2027; Promising Research into Developing Efficient MS Therapies to Prove Beneficial for the Market: Fortune Business Insights™ Pune, July 30, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. High...